9020 POSTER DISCUSSION Use of Bevacizumab (BV) After Induction Therapy is Associated With Survival Benefit in Patients (pts) With Non-small Cell Lung Cancer (NSCLC) in the ARIES Observational Cohort Study (OCS)
2011 ◽
Vol 47
◽
pp. S598
◽
2014 ◽
Vol 9
(9)
◽
pp. 1332-1339
◽
Keyword(s):
2016 ◽
Vol 25
(5)
◽
pp. 569-577
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7618-7618
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7619-7619
◽
2009 ◽
Vol 7
(2)
◽
pp. 507
◽
Keyword(s):